{"document_type": "article", "snippet": "Until there is better data, the F.D.A. should consider suspending sales of Essure, a contraceptive implant.", "type_of_material": "Editorial", "web_url": "http://www.nytimes.com/2015/10/14/opinion/safety-questions-about-a-birth-control-device.html", "subsection_name": null, "blog": [], "section_name": "Opinion", "source": "The New York Times", "pub_date": "2015-10-14T00:00:00Z", "word_count": "379", "slideshow_credits": null, "news_desk": "Editorial", "byline": {"original": "By THE EDITORIAL BOARD", "person": [], "organization": "THE EDITORIAL BOARD"}, "abstract": "Editorial urges FDA to suspend sales of birth control implant Essure, in light of mounting complaints that device has harmed women; notes over 5,000 women have reported harmful effects tied to Essure; calls for independent investigation into device and says it should be discontinued until better data is available.", "keywords": [{"value": "Editorials", "rank": "1", "name": "subject", "is_major": "Y"}, {"value": "Birth Control and Family Planning", "rank": "2", "name": "subject", "is_major": "Y"}, {"value": "Food and Drug Administration", "rank": "3", "name": "organizations", "is_major": "Y"}, {"value": "Medical Devices", "rank": "4", "name": "subject", "is_major": "N"}, {"value": "Clinical Trials", "rank": "5", "name": "subject", "is_major": "N"}, {"value": "American College of Obstetricians and Gynecologists", "rank": "6", "name": "organizations", "is_major": "N"}, {"value": "Planned Parenthood Federation of America", "rank": "7", "name": "organizations", "is_major": "N"}, {"value": "Health and Human Services Department", "rank": "8", "name": "organizations", "is_major": "N"}, {"value": "Implants", "rank": "9", "name": "subject", "is_major": "Y"}], "print_page": "24", "multimedia": [{"subtype": "wide", "legacy": {"wideheight": "126", "wide": "images/2015/10/14/opinion/14wed3web/14wed3web-thumbWide.jpg", "widewidth": "190"}, "type": "image", "width": 190, "height": 126, "url": "images/2015/10/14/opinion/14wed3web/14wed3web-thumbWide.jpg"}, {"subtype": "xlarge", "legacy": {"xlargeheight": "400", "xlargewidth": "600", "xlarge": "images/2015/10/14/opinion/14wed3web/14wed3web-articleLarge.jpg"}, "type": "image", "width": 600, "height": 400, "url": "images/2015/10/14/opinion/14wed3web/14wed3web-articleLarge.jpg"}, {"subtype": "thumbnail", "legacy": {"thumbnail": "images/2015/10/14/opinion/14wed3web/14wed3web-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "type": "image", "width": 75, "height": 75, "url": "images/2015/10/14/opinion/14wed3web/14wed3web-thumbStandard.jpg"}], "lead_paragraph": "Until there is better data, the F.D.A. should consider suspending sales of Essure, a contraceptive implant.", "headline": {"kicker": "Editorial", "content_kicker": "Editorial", "print_headline": "Safety Questions About a Birth Control Device   ", "main": "Safety Questions About a Birth Control Device "}, "_id": "561e026438f0d86f05abece0"}